get a key
steadybase-$ company REPL
account_id none on file
legal_name Replimune Group, Inc.
ticker REPL
cik 1737953
domain replimune.com
entry_point_account_id none on file
name Replimune Group Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 14 executives 14 family 0
why_nownone on file
callsnone on file
filings
Sushil Patel, Ph.D. 55 Chief Executive Officer and Director

filing / Jul 29, 2026 / receipt

Madhavan Balachandran (2) 75 Director

filing / Jul 29, 2026 / receipt

Kapil Dhingra, M.B.B.S. (1)(2) 66 Director

filing / Jul 29, 2026 / receipt

Michael Goller (3) 51 Director

filing / Jul 29, 2026 / receipt

Christy Oliger (1)(2) 56 Director

filing / Jul 29, 2026 / receipt

Veleka R. Peeples-Dyer (3)(4)(5) 54 Director

filing / Jul 29, 2026 / receipt

Paolo Pucci (2)(3)(6) 65 Director

filing / Jul 29, 2026 / receipt

Joseph Slattery (1)(4) 61 Director

filing / Jul 29, 2026 / receipt

Dieter Weinand (3)(4) 65 Lead Independent Director

filing / Jul 29, 2026 / receipt

Philip Astley-Sparke is one of our co-founders and has served as a member of our Board since our formation in 2015 and as our Executive Chairman since April 2024.

filing / Jul 29, 2026 / receipt

Sushil Patel, Ph.D. | Chief Executive Officer

filing / Jul 29, 2026 / receipt

Emily Hill | Chief Financial Officer

filing / Jul 29, 2026 / receipt

executives
Adam Soll Executive Director, Controller linkedin receipt
Andrew Schwendenman Chief Accounting Officer (CAO) linkedin receipt
Christy Oliger Director - receipt
Dieter Weinand Lead Independent Director - receipt
Emily Hill Chief Financial Officer - receipt
Joseph Slattery Director - receipt
Kapil Dhingra, M.B.B.S. Director - receipt
Konstantinos Xynos, M.D. Chief Medical Officer - receipt
Madhavan Balachandran Director - receipt
Michael Goller Director - receipt
Paolo Pucci Director - receipt
Philip Astley-Sparke Executive Chairman - receipt
Sushil Patel, Ph.D. Chief Executive Officer and Director - receipt
Veleka R. Peeples-Dyer Director - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changes
2023-05-18 Chief Financial Officer, departed sec_8k
2023-05-18 Vice President, appointed sec_8k
mcp_package_hint
steadybase-$